Marketing Expert with over 5+ years of experience in Business Development and Marketing Management. My background includes staffing analysis, strategic planning, business & partnership development, organizational identity, employee identification & development, client relations, and program development.
Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin, claims Roots Analysis
Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise and supporting infrastructure to manufacture a wide variety of radioisotopes, for in-house use, or as a contract service, claims Roots Analysis
Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry; interestingly, the majority (>55%) of such service providers firms are based in Europe, claims Roots Analysis
Over 100 industry players are engaged in evaluating the potential of several prescription (validated through clinical research) digital therapeutic solutions to prevent / treat various chronic diseases
The Antibody Discovery Services Market is estimated to be worth around USD 6.5 billion by 2030 instead the antibody discovery platforms market is anticipated to be worth close to USD 6 billion by 2030, predicts Roots Analysis
Drugrepurposing enables drug developers to optimize on past efforts andexpenditure, thereby, offering a viable life cycle management strategy formarketed products and opportunities to re-evaluate failed / shelved drugdevelopment programs